Skip to main content
. Author manuscript; available in PMC: 2015 Feb 20.
Published in final edited form as: J Heart Lung Transplant. 2014 Mar 27;33(7):749–757. doi: 10.1016/j.healun.2014.03.004

Figure 1.

Figure 1

Peri-operative morbidity and mortality of recipients treated with cromolyn sodium. In this experiment, 11 of 36 rats receiving lungs subjected to prolonged ischemia developed peri-operative morbidity and mortality with histologic evidence of parenchymal necrosis and diffuse alveolar hemorrhage. In contrast, no peri-operative morbidity or mortality developed in those recipients treated with pre-operative cromolyn, despite receiving lungs subjected to prolonged ischemia. Analysis using a 2 × 2 contingency table showed a significant improvement in peri-operative complications and death after treatment with cromolyn (p = 0.045).